Immunome (IMNM) Metrics: History & Chart

Immunome, Inc.(IMNM)

Biotechnology · Bothell, WA

$20.19-0.98 (-4.63%)

Delayed quote: Oct 6, 2026, 10:50 AM EDT

About Immunome, Inc.

Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. It is also developing preclinical assets, including IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, such as IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.

Bothell, WA

247 employees

www.immunome.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Clay Siegall

View full financials

Third-Party DCF Estimate (FMP)	$7.38
Price Gap vs Third-Party Estimate	-65.14%

7D Total Return	-2.35%
30D Total Return	-20.89%
YTD Total Return	-1.44%
1Y Total Return	+71.00%
3Y Total Return	+181.88%
5Y Total Return	+15.25%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-1.44%
2025	+102.26%
2024	-0.75%
2023	+384.16%
2022	-82.95%
2021	+33.88%
2020

CAGR TTM	+70.56%
CAGR 3Y	+41.25%
CAGR 5Y	+2.88%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

IMNM Valuation Metrics

IMNM Stock Price Metrics

IMNM Dividend Metrics

IMNM Growth Rate Metrics

IMNM Discounted Cash Flow Metrics

IMNM Returns By Period

IMNM Yearly Returns

IMNM Average Annual Returns By Period (CAGR)

IMNM Revenue Metrics

IMNM PE Ratio Metrics

IMNM PS Ratio Metrics

IMNM PB Ratio Metrics

IMNM Price to Free Cash Flow Ratio Metrics

IMNM Debt to Equity Ratio Metrics

IMNM PEG Ratio Metrics

IMNM FCF Yield

IMNM Earnings Yield

IMNM EBITDA Yield

IMNM OCF Yield

IMNM EV/EBIT Ratio Metrics

IMNM EV/EBITDA Ratio Metrics

IMNM EV/Assets Ratio Metrics

IMNM EV/Sales Ratio Metrics

IMNM Current Ratio Metrics

IMNM Quick Ratio Metrics

IMNM ROIC Metrics

IMNM Return on Assets Metrics

IMNM Return on Equity Metrics

IMNM Net Profit Margin Metrics

IMNM Gross Profit Margin Metrics

IMNM Tax Rate Metrics

PS Ratio	739.69
PS Ratio Avg TTM	212.63
PS Ratio Avg 3Y	79.07
Current VS TTM Avg	+247.88%
Current VS 3Y Avg	+835.51%
Current VS 5Y Avg	+1147.79%

PB Ratio	4.57
PB Ratio Avg TTM	5.14
PB Ratio Avg 3Y	3.69
Current VS TTM Avg	-11.02%
Current VS 3Y Avg	+23.77%
Current VS 5Y Avg	+38.72%

PFCF Ratio	113.47
PFCF Ratio Avg TTM	51.80
PFCF Ratio Avg 3Y	51.80
Current VS TTM Avg	+119.04%
Current VS 3Y Avg	+119.04%
Current VS 5Y Avg	+119.04%

Debt/Equity Ratio	0.01
Debt/Equity Ratio Avg TTM	0.01
Debt/Equity Ratio Avg 3Y	0.01
Current VS TTM Avg	-15.46%
Current VS 3Y Avg	-20.74%
Current VS 5Y Avg	-16.47%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	0.88%
FCF Yield Avg TTM	2.45%
FCF Yield Avg 3Y	2.45%
Current VS TTM Avg	-64.12%
Current VS 3Y Avg	-64.12%
Current VS 5Y Avg	-64.12%

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	3.86
Ev/Assets Ratio Avg TTM	3.88
Ev/Assets Ratio Avg 3Y	2.26
Current VS TTM Avg	-0.53%
Current VS 3Y Avg	+70.78%
Current VS 5Y Avg	+136.70%

Ev/Sales Ratio	595.48
Ev/Sales Ratio Avg TTM	146.51
Ev/Sales Ratio Avg 3Y	65.24
Current VS TTM Avg	+306.45%
Current VS 3Y Avg	+812.76%
Current VS 5Y Avg	+885.86%

Current Ratio	15.08
Current Ratio Avg TTM	14.49
Current Ratio Avg 3Y	8.41
Current VS TTM Avg	+4.02%
Current VS 3Y Avg	+79.27%
Current VS 5Y Avg	+100.32%

Quick Ratio	15.08
Quick Ratio Avg TTM	14.49
Quick Ratio Avg 3Y	8.41
Current VS TTM Avg	+4.02%
Current VS 3Y Avg	+79.25%
Current VS 5Y Avg	+100.26%

ROIC	(51.06%)
ROIC Avg 3Y	(89.23%)
ROIC Avg 5Y	(94.86%)
Current VS 3Y Avg	+42.77%
Current VS 5Y Avg	+46.17%
Current VS 10Y Avg	+49.19%

ROA	(44.98%)
ROA Avg TTM	(13.14%)
ROA Avg 3Y	(12.64%)
Current VS TTM Avg	-242.36%
Current VS 3Y Avg	-255.73%
Current VS 5Y Avg	-156.38%

ROE	(48.43%)
ROE Avg TTM	(56.67%)
ROE Avg 3Y	(84.34%)
Current VS TTM Avg	+14.54%
Current VS 3Y Avg	+42.58%
Current VS 5Y Avg	+54.58%

Net Profit Margin	(3059.99%)
Net Profit Margin Avg TTM	(216.17%)
Net Profit Margin Avg 3Y	(937.91%)
Current VS TTM Avg	-1315.52%
Current VS 3Y Avg	-226.26%
Current VS 5Y Avg	-435.17%

Gross Profit Margin	57.43%
Gross Pft Margin Avg TTM	16.41%
Gross Pft Margin Avg 3Y	57.18%
Current VS TTM Avg	+249.90%
Current VS 3Y Avg	+0.44%
Current VS 5Y Avg	+77.93%

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	+100.00%